Dinesh Kumar

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 17

Top Topics

Combination Therapy

Epidermal Growth Factor Receptor

Artificial Intelligence

Top Venues

AAPS PharmSciTech

Drug delivery and translational research

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Anuj A Biswas, Madhukiran R Dhondale, Ashish Kumar Agarwal, Dolores Remedios Serrano, Brahmeshwar Mishra, Dinesh Kumar
Advancements in microneedle fabrication techniques: artificial intelligence assisted 3D-printing technology. Drug delivery and translational research 14 (6) (2024)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Saurabh Kumar Srivastava, Dinesh Kumar, Umesh Kumar Patil, Avanish Singh Parmar, Sanjay Singh, Ashish Kumar Agarwal
Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach. Pharmaceutics 16 (7) (2024)
Anuj A Biswas, Madhukiran R Dhondale, Ashish Kumar Agarwal, Dolores Remedios Serrano, Brahmeshwar Mishra, Dinesh Kumar
Advancements in microneedle fabrication techniques: artificial intelligence assisted 3D-printing technology. Drug delivery and translational research (2024)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Saurabh Kumar Srivastava, Dinesh Kumar, Umesh Kumar Patil, Avanish Singh Parmar, Sanjay Singh, Ashish Kumar Agarwal
Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach. Pharmaceutics 16 (7) (2024)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Saurabh Kumar Srivastava, Dinesh Kumar, Umesh Kumar Patil, Avanish Singh Parmar, Sanjay Singh, Ashish Kumar Agarwal
Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach. Pharmaceutics 16 (7) (2024)
Maan Singh, Harsh Barua, Vaskuri G S Sainaga Jyothi, Madhukiran R Dhondale, Amritha G Nambiar, Ashish Kumar Agarwal, Pradeep Kumar, Nalini R Shastri, Dinesh Kumar
Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems. Pharmaceutics 15 (4) (2023)
Madhukiran R Dhondale, Pradip Thakor, Amritha G Nambiar, Maan Singh, Ashish Kumar Agarwal, Nalini R Shastri, Dinesh Kumar
Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs. Pharmaceutics 15 (1) (2023)
Madhukiran R Dhondale, Pradip Thakor, Amritha G Nambiar, Maan Singh, Ashish Kumar Agarwal, Nalini R Shastri, Dinesh Kumar
Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs. Pharmaceutics 15 (1) (2023)
Hussain Ali, Prakash Muthudoss, Chirag Chauhan, Ilango Kaliappan, Dinesh Kumar, Amrit Paudel, Gobi Ramasamy
Machine Learning-Enabled NIR Spectroscopy. Part 3: Hyperparameter by Design (HyD) Based ANN-MLP Optimization, Model Generalizability, and Model Transferability. AAPS PharmSciTech 24 (8) (2023)
Madhukiran R Dhondale, Pradip Thakor, Amritha G Nambiar, Maan Singh, Ashish Kumar Agarwal, Nalini R Shastri, Dinesh Kumar
Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs. Pharmaceutics 15 (1) (2023)
Maan Singh, Harsh Barua, Vaskuri G S Sainaga Jyothi, Madhukiran R Dhondale, Amritha G Nambiar, Ashish Kumar Agarwal, Pradeep Kumar, Nalini R Shastri, Dinesh Kumar
Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems. Pharmaceutics 15 (4) (2023)
Madhukiran R Dhondale, Pradip Thakor, Amritha G Nambiar, Maan Singh, Ashish Kumar Agarwal, Nalini R Shastri, Dinesh Kumar
Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs. Pharmaceutics 15 (1) (2023)
Maan Singh, Harsh Barua, Vaskuri G S Sainaga Jyothi, Madhukiran R Dhondale, Amritha G Nambiar, Ashish Kumar Agarwal, Pradeep Kumar, Nalini R Shastri, Dinesh Kumar
Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems. Pharmaceutics 15 (4) (2023)
Maan Singh, Harsh Barua, Vaskuri G S Sainaga Jyothi, Madhukiran R Dhondale, Amritha G Nambiar, Ashish Kumar Agarwal, Pradeep Kumar, Nalini R Shastri, Dinesh Kumar
Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems. Pharmaceutics 15 (4) (2023)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, Pradeep Kumar, Pradeep Kumar Bolla, Dinesh Kumar, Ashish Kumar Agarwal
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, Anusmita Shekher, Subash C Gupta, Shreyasi Majumdar, Sairam Krishnamurthy, Sanjay Singh, Dinesh Kumar, Ashish Kumar Agarwal
Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer. Life (Basel, Switzerland) 12 (8) (2022)
Amritha G Nambiar, Maan Singh, Abhishek R Mali, Dolores R Serrano, Rajnish Kumar, Anne Marie Healy, Ashish Kumar Agrawal, Dinesh Kumar
Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions. AAPS PharmSciTech 23 (7) (2022)